Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $11.85 which represents a slight increase of $1.71 or 16.86% from the prior close of $10.14. The stock opened at $12.6 and ...

In a report released yesterday, Joseph Reagor from Roth MKM reiterated a Buy rating on Avino Silver & Gold (ASM – Research Report), with a ...

Roth MKM reduced its Reddit stock rating to Neutral from Buy on Wednesday, while lifting the price target to $195 from $116, due to a more balanced near-term risk-reward profile at current valuation.

Roth MKM raised the firm’s price target on Redwire (RDW) to $30 from $16 and keeps a Buy rating on the shares following the company’s deal to ...

LivePerson Inc (LPSN) stock saw a modest uptick, ending the day at $1.36 which represents a slight increase of $0.03 or 2.26% from the prior close of $1.33. The stock opened at $1.33 and touched a low ...

Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Roth MKM keeps a Buy rating and $38 price target on Digi International (DGII) following its non-deal roadshow with the management team. The firm comes away from the discussions “cautiously ...

Roth MKM lowered the firm’s price target on Mattel (MAT) to $20 from $21 and keeps a Neutral rating on the shares ahead of ...

Roth MKM last night initiated coverage of Entrada Therapeutics (TRDA) with a Buy rating and $29 price target Entrada is an early-stage biopharma that seeks to solve a key bottleneck, which is ...

We recently published a list of Roth MKM’s AI & Non-AI Stocks To Be Cautious About: 15 Stocks Bank With $60 Billion Capital Raise Is Watching. In this article, we are going to take a look at where ...